Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PT2385 |
Trade Name | |
Synonyms | |
Drug Descriptions |
PT2385 is a hypoxia inducible factor-2alpha (EPAS1, HIF2A) inhibitor that leads to dissociation of HIF-2 complexes, thereby suppressing expression of HIF2A target genes, and potentially resulting in antitumor activity (PMID: 31727677). |
DrugClasses | HIF2A Inhibitor 6 |
CAS Registry Number | 1672665-49-4 |
NCIT ID | C119618 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Nivolumab + PT2385 | Nivolumab PT2385 | 0 | 1 |
PT2385 | PT2385 | 0 | 3 |